<PAGE>
-----------------------------
OMB APPROVAL
UNITED STATES OMB Number: 3235-0145
SECURITIES AND EXCHANGE COMMISSION Expires: October 31, 1994
Washington, D.C. 20549 Estimated average burden
hours per response... 14.90
-----------------------------
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 3)*
Hologic, Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
- --------------------------------------------------------------------------------
(Title of Class of Securities)
436440-10-1
----------------------------
(CUSIP Number)
Check the following box if a fee is being paid with this statement [_]. (A fee
is not required only if the filing person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7).
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 5 Pages
<PAGE>
- --------------------- -----------------
CUSIP No. 436440-10-1 13G Page 2 of 5 Pages
- --------------------- -----------------
- -------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
S. David Ellenbogen
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_]
(b) [_]
Not applicable
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
Number of
Shares 284,980
----------------------------------------------------------------
Beneficially 6 SHARED VOTING POWER
Owned by
Each
----------------------------------------------------------------
Reporting 7 SOLE DISPOSITIVE POWER
Person
With 284,980
----------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
284,980
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
X
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
6.76%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
PAGE 2 OF 5 PAGES
<PAGE>
Item 1(a)
Name of Issuer: Hologic, Inc.
Item 1(b)
Address of Issuer's Principal Executive Offices: 590 Lincoln Street, Waltham,
Massachusetts 02154.
Item 2(a)
Name of Person Filing: S. David Ellenbogen
Item 2(b)
Address of Principal Business Office or, if none, Residence: 590 Lincoln Street,
Waltham, Massachusetts 02154.
Item 2(c)
Citizenship: United States
Item 2(d)
Title of Class of Securities: Common Stock, $.01 par value.
Item 2(e)
CUSIP Number: 436440-10-1
Item 3
Not Applicable
Item 4
Ownership:
(a) Amount Beneficially Owned: 284,980 shares of Common Stock. Includes
7,190 shares held by Mr. Ellenbogen as trustee, of which Mr. Ellenbogen
disclaims beneficial ownership; also includes options to purchase 28,440
shares of Common Stock which are currently exercisable. Certain of these
options are subject to stockholder approval. Excludes 27,150 shares held
by, or in trust for, Mr. Ellenbogen's children and grandchildren.
(b) Percent of Class: 6.76%
(c) Number of shares as to which such person has:
Page 3 of 5 pages
<PAGE>
(i) sole power to vote or direct the vote: 284,980
(ii) shared power to vote or to direct the vote: None
(iii) sole power to dispose or to direct the disposition: 284,980
(iv) shared power to dispose or to direct the disposition: None
Item 5
Ownership of Five Percent or Less of Class: Not Applicable
Item 6
Ownership of More than Five Percent on Behalf of Another Person: Not Applicable
Item 7
Identification and Classification of the Subsidiary Which Acquired the Security
Being Reported on By the Parent Holding Company: Not Applicable
Item 8
Identification and Classification of Members of the Group: Not Applicable
Item 9
Notice of Dissolution of Group: Not Applicable
Item 10
Certification: Not Applicable
Page 4 of 5 pages
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February 13, 1996
- ------------------
Date
/s/ S. David Ellenbogen
- ----------------------
Signature
S. David Ellenbogen/Chairman and CEO
- ------------------------------------
Name/Title
Page 5 of 5 pages
